Cooperation Invitation | Frost & Sullivan is about to release the '2026 Global Longevity Medical Institution Comprehensive Diagnosis and Treatment Capability Research Report'.
Cooperation Invitation | Frost & Sullivan is about to release the '2026 Global Longevity Medical Institution Comprehensive Diagnosis and Treatment Capability Research Report'.
With the deepening aging population and the continuous escalation of health needs, how to extend healthy life expectancy, maintain physical function and quality of life has become an increasingly significant issue in the field of medical health. Focusing on aging assessment, disease risk identification, individualized intervention and continuous health management, global longevity medicine institutions are exploring various medical services and operational pathways, posing higher demands on scientific evidence, service integration and long-term management capabilities.
Based on ongoing research into the global medical health industry and longevity medicine practices, Frost & Sullivan (hereafter referred to as 'Frost & Sullivan') is about to release the '2026 Comprehensive Diagnosis and Treatment Capability Report of Global Longevity Medicine Institutions'. The report will take the patient treatment pathway as the main focus, conducting research on the actual service capabilities, medical models and operational models of globally representative institutions, emphasizing disease treatment priority and evidence-based and compliant principles, providing a reference for patients and their families, medical institutions, investment institutions and industry participants.

The report will adopt a global perspective, organizing representative longevity clinics, destination sanatoriums and hospitals and medical centers offering longevity services by country, and, in combination with official public information, relevant research and institutional materials, study their clinical positioning, service scope and organizational methods, and distinguish between delivery forms such as conducted by the institution itself, collaborative within the same group and external referral.
At the medical model level, the report will conduct research around two treatment pathways: one covers comprehensive assessment, individualized longevity treatment, monitoring and re-evaluation; the other, using suspected tumors and coronary heart disease requiring intervention or surgery as a common scenario, outlines the processes of suspending the original plan, initiating a full-specialist joint consultation, prioritizing disease treatment, supportive treatment and original team return management, and clarifies the integration and responsibility allocation for each stage.
At the institutional practice level, the report will examine the service capabilities and implementation of representative institutions from ten dimensions: physical examination and in-hospital examinations, disease treatment priority strategy, disease diagnosis and treatment conducted by the institution, disease treatment coordination, supportive treatment, post-treatment return, longevity medicine treatment, research, medical education and non-inpatient accommodation. It will also analyze cases such as independent longevity clinics, destination sanatoriums, hospital longevity centers and longevity-themed general hospitals to explore the integration mechanism between patient reception, specialist collaboration and long-term management under different medical models.
At the operational level, the report will outline revenue sources such as memberships, treatment courses, specialized diagnosis and treatment and hospitalization, analyze the division of labor between hospitals and clinics, team and facility investments, and the support provided by research and medical education for clinical services, and discuss the replication conditions and sustainable operation foundation for service capabilities. Finally, it will form research conclusions based on the needs of patients to choose an institution and the actual operational capabilities and expansion conditions that investors are concerned about, and outline the industry development direction regarding clinical integration, talent cultivation and research translation.

Frost & Sullivan cordially invites longevity medicine and health management institutions, medical service groups, testing and digital health companies, insurance institutions and investment institutions to engage in exchanges, exploring special research, professional content and consulting cooperation around shared industry issues.
Assess the global landscape and grasp the development direction
Conducting research and exchange activities around the global longevity medicine market, health needs and institutional practice, this report provides a reference for enterprises' market positioning, service layout and business planning.
Focus on medicine and operation, deepen practical research
Combining the assessment technologies, intervention pathways, continuous management and operational methods that institutions are concerned about, explore special research, case analysis and professional content cooperation.
Connect with industrial resources, explore development opportunities
Exploring more targeted research and consulting cooperation around topics such as market entry, service network construction, industrial synergy and investment opportunities.

Frost & Sullivan continues to monitor the development of global longevity medicine and related fields, conducting research on medical services, technical applications and operational models, and providing market insights and business references for industry participants.
If you are interested in the development of longevity medicine and related fields, or have relevant needs in market research, industry consulting, business layout and professional exchange, please feel free to contact us. Frost & Sullivan looks forward to maintaining communication with medical institutions, related enterprises, professionals and investment institutions to jointly explore the trends and opportunities for the industry's development.
Please contact us
Direct contact with the project team is welcome
Frost & Sullivan China
Senior Partner and Managing Director Mao Hua
Email:
fred.mao@frostchina.com
Frost & Sullivan China
Consulting Director Wang Peng
Email:
aaron.wang@frostchina.com

Contact: marketing@frostchina.com


